KEITH SIERACKI: Open Payments
NPI 1760436232 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 77 payments from 13 companies in 2025. Trend: 2023 $1,626 · 2024 $1,545 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $384 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $194 |
| PFIZER INC. | 10 | $174 |
| E.R. Squibb & Sons, L.L.C. | 9 | $141 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| BridgeBio Pharma, Inc. | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Philips North America LLC | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
Products named: LEQVIO, LifeVest, VYNDAQEL, CAMZYOS, EVKEEZA, Attruby, VERQUVO, ELIQUIS.
Industry payments across FL — which companies pay providers there.
